Navigation Links
Insmed Provides Update on Supply of IPLEX(TM)
Date:7/27/2009

RICHMOND, Va., July 27 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today announced that, effective immediately, the Company will cease the supply of IPLEX((TM)) to any new patients. In addition, the Company will not initiate further clinical trials with IPLEX((TM)) at this time. The Company has determined that its limited inventory on hand must be conserved for the treatment of existing patients.

Following the previously announced sale of Insmed's Boulder, Colorado manufacturing facility to Merck & Co., Inc. in March 2009, Insmed no longer has the capability to manufacture IPLEX((TM)), an extremely complicated drug to produce. Moreover, any agreement with a third party to undertake the manufacture of IPLEX((TM)), if it was economically feasible and could be arranged, would not result in production of additional quantities of IPLEX(TM) for at least 12 to 18 months.

There are approximately 70 patients who currently receive IPLEX(TM), 12 in the U.S. and the remainder around the rest of the world. Most of the patients receive IPLEX(TM) pursuant to a court-ordered Extended Access Program (EAP) for Amyotrophic Lateral Sclerosis (ALS) in Italy. The 12 U.S. patients are being treated for ALS under single patient Investigational New Drug applications approved by the U.S. Food and Drug Administration. The Company believes that it has sufficient IPLEX(TM) inventory to supply these patients for no more than 24 months.

The Company intends to analyze the on-going data collected for various indications, including myotonic muscular dystrophy and ALS, and assess the overall IPLEX(TM) development program, including possible IPLEX(TM) manufacturing options with third parties and possible future clinical trials. Initiation of the Phase II clinical trial fo
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
2. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
3. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
4. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
5. Insmed to Present at Upcoming Healthcare Conferences
6. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
7. President Obamas Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model
8. Study provides documentation that tumor stem-like cells exist in benign tumors
9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
10. International Isotopes Inc. Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction Process Plant
11. Leading Los Angeles Clinic (laserandveinclinic.com) Provides Top Notch Aesthetic Laser Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 A raucous childhood ... come together to form author Nancy Chovancek’s laughter-filled new ... is a collection of short stories that prove the ... fun. With a positive message of empowerment and resilience, ... is a proven author with two books under her ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Diabetes currently ... the Telegraph in August 2014, scientists made several ... diabetes, but still failed. The article indicates that cure ... this existing fact, there are many forward-thinking entrepreneurs and ... treatment in a natural way. Dr. Kenneth Pullman is ...
(Date:9/17/2014)... September 17, 2014 In honor of ... offers tips to health IT professionals for gaining a ... recent study by HIMSS shows demand for qualified health ... candidate’s skill set is the differentiating factor when filling ... an IT professional that has clinical workflow and terminology ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 On October ... wellness to the lineup at Techmanity, a celebration of ... next generation of tech events,” Techmanity will host the ... excited to join the ranks of Cisco, PayPal, Samsung, ... ever Silicon Valley Technology Conference. , Voom was created ...
(Date:9/17/2014)... 17, 2014 Presence Technology, a ... launched Presence Suite 10.0, which incorporates significant enhancements ... customer experience. , The Contact Center Agents and ... supervisors can get a better feel for the ... contributing most and who requires additional coaching or ...
Breaking Medicine News(10 mins):Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2
... a 15 Percent Increase in Prescription Drug,Costs ... from HealthLeaders-InterStudy, NASHVILLE, Tenn., July 21 ... market intelligence, reports that Excellus,BlueCross BlueShield will ... programs and public education efforts. According to ...
... July 21 Sound Pharmaceuticals (SPI) has,received an ... $1.6 million,to optimize its lead drug candidate for ... regenerating auditory sensory cells,within the inner ear of ... CKI. CKIs shut down cell division or proliferation ...
... Neurologic and Orthopedic Hospital of Chicago offers information on prevention and ... downloadable pdf, the reference tool offers tips for reducing risks, including ... ... 21, 2008 -- It's estimated that more than 1.4 million women ...
... - Organization Seeks Broad Industry & Allied Support -, ... -- Building,on the momentum of the CATalyst Summit in ... its formation to address alarming,statistics about feline health care ... manager, Pfizer Animal Health will serve as chair., ...
... common sense measures can reduce the risk, expert says , , SATURDAY, ... serious injury and death among elderly people in the United States, ... American Geriatric Society (AGS). , "There are many steps people can ... Something as small as using a night light in a dark ...
... But giving mice on the wagon an antidepressant restored brain,s ... News) -- Giving up your few drinks a day may ... , "Our research in an animal model establishes a causal ... author Clyde W. Hodge, a professor of psychiatry and pharmacology ...
Cached Medicine News:Health News:New York's Excellus BlueCross BlueShield to Continue Generic Medication Promotion to Help Control Costs 2Health News:Sound Pharmaceuticals Receives Additional DoD Funding for Its Hearing Regeneration Product 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 2Health News:Complimentary Sports Injury Prevention Pamphlet for Women Offered by NOHC of Chicago 3Health News:CATalyst Council Forms to Address Feline Health Care 2Health News:CATalyst Council Forms to Address Feline Health Care 3Health News:Falls Are Top Cause of Injury, Death Among Elderly 2Health News:Research Finds Causal Link Between Ending Drinking, Depression 2
(Date:9/16/2014)... 2014 Research and Markets has announced ... report to their offering. Animal vaccines ... Animal vaccines are generally prepared from weakened or dead microbes ... state. Some of the animal vaccines are also formulated using ... or toxic components. These components act as ...
(Date:9/16/2014)... Wash. , Sept. 16, 2014 /PRNewswire/ ... a late stage development company engaged primarily ... medical isotopes for diagnostic and therapeutic applications, ... for technology related to its brachytherapy products.  ... arise from its license from Battelle, under ...
(Date:9/16/2014)... Surgeons at The Children,s Hospital of ... the first successful use of a SynCardia temporary Total ... failing Fontan circulation to bridge him to a heart ... the patient received a Fontan circulation procedure to address ... Fontan operation is the final planned palliative operation for ...
Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 413-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 213-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery 3
... Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE ... Taylor, one of the Company,s funded researchers, will ... on SNS-01, Senesco,s multiple myeloma drug candidate, at ... Cancer Institute (NCI)-European Organization for Research and Treatment ...
... Nov. 12 Ionian Technologies, Inc. and Roche ... based on Ionian,s rapid isothermal nucleic acid amplification ... applications and customers for the technology and will ... exclusive manufacturing rights for these specific opportunities upon ...
Cached Medicine Technology:Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 3
This handheld reference is a practical guide to established surgical oncology principles for each organ system....
The Editors and Contributors are a virtual "Who's Who" in surgery, and they have prepared an outstanding program that provides expert advice on a full range of problems. Destined to be the "gold stan...
The First Aid for the Surgery Clerkship is designed to prepare for the surgery clerkship examination and provides clinical diagnosis and treatment of many of the problems seen by surgeons....
CURRENT Consult: Surgery brings you authoritative clinical answers on more than 360 surgically treated disorders in the most efficient format, perfectly devised for the busy physician....
Medicine Products: